CVS Health Corp vs Super Micro Computer Inc — how do they compare? CVS Health Corp trades at $85.76 (market cap $112.29B), while Super Micro Computer Inc trades at $43.42 (market cap $28.10B). The key difference: CVS Health Corp is far larger — about 4× Super Micro Computer Inc's market cap, and CVS Health Corp pays a 3.03% dividend while Super Micro Computer Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Super Micro Computer Inc for 19 Days on average.
| CVS | SMCI | |
|---|---|---|
Market Cap | $112.29B | $28.10B |
Volume | 7,763,676 | 38,581,805 |
Sector | Health | Technology |
52-Week High | $110.60 | $57.98 |
52-Week Low | $70.08 | $20.53 |
Typical Hold Time | 83 Days | 19 Days |
Enterprise Value | $174.64B | $33.56B |
Dividend Yield | 3.03% | — |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% on the day, with a bullish technical signal and strong analyst support. Recent earnings beats in Q1 and Q2 2026, alongside steady revenue growth to $402.07B in 2025, highlight operational strength. The stock's valuation appears attractive with a P/E of 23.17 and P/S of 0.27, while a consensus price target of $111.20 suggests significant upside potential. Positive news includes Aetna's 2027 Medicare plan enhancements and a declared quarterly dividend.
The outlook for CVS remains positive, driven by earnings momentum and strategic initiatives in healthcare services. Key risks include reimbursement pressures and regulatory scrutiny, but Wall Street's 85% buy rating and institutional interest underscore confidence. Investors should weigh the stock's growth prospects against margin volatility and debt levels, with the current price offering a favorable entry point relative to targets.
Super Micro Computer (SMCI) trades at $44.95, up 3.43% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with revenue growth from $22B to $39.1B projected for 2026, net income margin expansion to 5.7%, and consistent earnings beats. Recent AI server demand and NVIDIA Vera Rubin shipments highlight business momentum, though RSI levels suggest potential near-term overbought conditions.
SMCI presents a compelling growth story with AI infrastructure expansion driving financial performance, trading at attractive valuations (P/E 13.12, P/S 0.76). However, investors face risks including margin pressure, competitive AI server market dynamics, and ongoing regulatory investigation. Analyst consensus remains mixed with 36% buy ratings despite price target below current levels at $42.33.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.
Read more on SMCI →